MZ

Maky Zanganeh

North America, California, United States, Los Altos

Description

Maky Zanganeh is the Founder/CEO at Maky Zanganeh & Associates. She attended Schiller International University

Investor Profile

Maky Zanganeh has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical Device.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Which angels does Maky Zanganeh often collaborate with?

RW
North America, California, United States, Palo Alto
Shared Deals: 3
JH
North America, Nevada, United States, Incline Village
Shared Deals: 1

What are some of recent deals done by Maky Zanganeh?

Summit Therapeutics

Abingdon, Oxfordshire, United Kingdom

Summit Therapeutics is a clinical-stage drug discovery and development company.

BiotechnologyHealth CareMedical DeviceTherapeutics
Post Ipo EquitySep 11, 2024
Amount Raised: $235,000,000
Summit Therapeutics

Abingdon, Oxfordshire, United Kingdom

Summit Therapeutics is a clinical-stage drug discovery and development company.

BiotechnologyHealth CareMedical DeviceTherapeutics
Post Ipo EquityJan 30, 2023
Amount Raised: $500,000,000
Summit Therapeutics

Abingdon, Oxfordshire, United Kingdom

Summit Therapeutics is a clinical-stage drug discovery and development company.

BiotechnologyHealth CareMedical DeviceTherapeutics
Post Ipo EquityMay 12, 2021
Amount Raised: $75,000,000